Patient experiences vary widely
Theres no nutritionist, no check-in schedule unless you set one, and no community forum
Tirzepatide is a once-weekly injectable medication that belongs to a class of drugs known as GIP/GLP-1 receptor agonists
Its not yet FDA-approved but widely administered by trained practitioners
Protection against degradation is related to the entrapment of the drug inside core of vesicle which provides protection till reaching site of absorption 27,28
Vorsanger MH, Subramanyam P, Weintraub HS, Lamm SH, Underberg JA, Gianos E, et al